Enhancing the delivery of erythropoietin and its variants into the ischemic brain

TheScientificWorldJournal

Volumn 9, Issue , 2009, Pages 967-969

  Hermann, Dirk M ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Biodistribution; Growth factor; Hematopoietic; Neuroprotection

Indexed keywords

ERYTHROPOIETIN; SIALIC ACID;

BLOOD CLOT LYSIS; BRAIN ISCHEMIA; BRAIN TISSUE; CARBAMOYLATION; CEREBROSPINAL FLUID; DRUG ABSORPTION; DRUG BINDING; DRUG DELIVERY SYSTEM; HUMAN; MOLECULAR WEIGHT; NEUROPROTECTION; NONHUMAN; REVIEW; STROKE;

ADMINISTRATION, INTRANASAL; ASIALOGLYCOPROTEINS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; HUMANS; STROKE;

ANIMALIA; PRIMATES;

EID: 77649282968     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2009.104     Document Type: Review

References (15)

1. Kilic, E., Dietz, G.P., Hermann, D.M., and Bähr, M. (2002) Intravenous TAT-Bcl-Xl is protective after middle cerebral artery occlusion in mice. Ann. Neurol. 52, 617-622.
2. Hermann, D.M., Kilic, E., Kügler, S., et al. (2001) Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice. Neurobiol. Dis. 8, 655-666.
3. Pardridge, W.M. (2007) Drug targeting to the brain. Pharm. Res. 24, 1733-1744.
4. Spudich, A., Kilic, E., Xing, H., et al. (2006) Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia. Nat. Neurosci. 9, 487-488.
5. Garcia Rodriguez, J.C. and Sosa Teste, I. (2009) The nasal route as a potential pathway for delivery of erythropoietin in the treatment of acute ischemic stroke in humans. The ScientificWorldJOURNAL 9, 970-981.
6. Brines, M.L., Ghezzi, P., Keenan, S., et al. (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. U. S. A. 97, 10526-10531.
7. Kilic, E., Kilic, U., Soliz, J., et al. (2005a) Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J. 19, 2026-2028.
8. Kilic, U., Kilic, E., Soliz, J., et al. (2005b) Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. FASEB J. 19, 249-251.
9. Ehrenreich, H., Hasselblatt, M., Dembowski, C., et al. (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol. Med. 8, 495-505.
10. Wiessner, C., Allegrini, P.R., Ekatodramis, D., et al. (2001) Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J. Cereb. Blood Flow Metab. 21, 857-864.
11. Leist, M., Ghezzi, P., Grasso, G., et al. (2004) Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305, 239-242.
12. Sosa, I., Cruz, J., Santana, J., et al. (2007) Paso de la molécula de eritropoyetina humana recombinante con bajo contenido de ácido siálico aplicada al sistema nervioso central por la vía intranasal en los modelos del meriones unguiculatus y el primate no humano Macaca fascicularis. Rev. Salud. Anim. 29, 1-6.
13. Kirkeby, A., Torup, L., Bochsen, L., et al. (2008) High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO). Thromb. Haemost. 99, 720-728.
14. Li, Y., Lu, Z., Keogh, C.L., et al. (2007) Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J. Cereb. Blood Flow Metab. 27, 1043-1054.
15. Li, Y., Lu, Z.Y., Ogle, M., and Wei, L. (2007) Erythropoietin prevents blood brain barrier damage induced by focal cerebral ischemia in mice. Neurochem. Res. 32, 2132-2141.